We are live on ! Find out more
CS

Candriam SCA Portfolio holdings

AUM $19.3B
1-Year Est. Return 39.18%
This Fund
S&P 500
This Quarter Est. Return
+10.4%
1 Year Est. Return
+39.18%
3 Year Est. Return
+109.85%
5 Year Est. Return
+149.31%
10 Year Est. Return
+617.16%
AUM
$20.1B
AUM Growth
+$951M
Cap. Flow
-$224M
Cap. Flow %
-1.12%
Top 10 Hldgs %
32.44%
Holding
721
New
63
Increased
299
Reduced
261
Closed
36

Top Buys

Rank Stock Value
1
ABBV icon
AbbVie
ABBV
+$55.1M
2
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$46.1M
3
BABA icon
Alibaba
BABA
+$45M
4
NEE icon
NextEra Energy
NEE
+$40.9M
5
AMZN icon
Amazon
AMZN
+$38.3M

Top Sells

Rank Stock Value
1
EQIX icon
Equinix
EQIX
+$50.3M
2
META icon
Meta Platforms (Facebook)
META
+$44.2M
3
PG icon
Procter & Gamble
PG
+$34.1M
4
ZTS icon
Zoetis
ZTS
+$33.6M
5
CAH icon
Cardinal Health
CAH
+$32.2M

Sector Composition

Rank Sector Weight
1 Technology 34.01%
2 Healthcare 26.73%
3 Financials 11.13%
4 Consumer Discretionary 7.93%
5 Communication Services 7.13%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TOL icon
276
Toll Brothers
TOL
$14B
$9.62M 0.05%
71,166
+32,028
+82% +$4.35M
CME icon
277
CME Group
CME
$96.1B
$9.54M 0.05%
34,944
-46,650
-57% -$12.7M
SMMT icon
278
Summit Therapeutics
SMMT
$10.7B
$9.46M 0.05%
540,662
+26,899
+5% +$506K
IMCR icon
279
Immunocore
IMCR
$1.72B
$9.36M 0.05%
269,729
CYTK icon
280
Cytokinetics
CYTK
$10.9B
$9.32M 0.05%
+146,631
New +$9.12M
CMCSA icon
281
Comcast
CMCSA
$84B
$9.29M 0.05%
310,634
-641,520
-67% -$18.3M
MRSH
282
Marsh
MRSH
$91.4B
$9.19M 0.05%
49,518
-247
-0.5% -$46.2K
BBY icon
283
Best Buy
BBY
$18.5B
$9.16M 0.05%
136,907
+121,230
+773% +$9.25M
HALO icon
284
Halozyme
HALO
$9.88B
$9.11M 0.05%
135,349
+55,366
+69% +$3.72M
AMT icon
285
American Tower
AMT
$81.3B
$9.09M 0.05%
51,758
+6,076
+13% +$1.11M
ED icon
286
Consolidated Edison
ED
$40.4B
$8.65M 0.04%
87,065
+7,425
+9% +$737K
TEAM icon
287
Atlassian
TEAM
$24.9B
$8.51M 0.04%
52,487
+11,384
+28% +$1.79M
WMB icon
288
Williams Companies
WMB
$86.7B
$8.45M 0.04%
140,502
+13,694
+11% +$828K
BCYC
289
Bicycle Therapeutics
BCYC
$280M
$8.44M 0.04%
1,192,279
+19,892
+2% +$147K
GM icon
290
General Motors
GM
$80B
$8.35M 0.04%
102,679
-11,009
-10% -$776K
NXT icon
291
Nextpower Inc
NXT
$14.7B
$8.35M 0.04%
95,834
-40,965
-30% -$3.71M
URI icon
292
United Rentals
URI
$66.5B
$8.32M 0.04%
10,281
-618
-6% -$536K
BMI icon
293
Badger Meter
BMI
$3.78B
$8.25M 0.04%
47,297
+5,230
+12% +$942K
EME icon
294
Emcor
EME
$35.7B
$8.23M 0.04%
13,455
-13,988
-51% -$9.06M
DELL icon
295
Dell
DELL
$262B
$8.2M 0.04%
65,140
-25,567
-28% -$3.6M
SLB icon
296
SLB Ltd
SLB
$72.6B
$8.18M 0.04%
213,215
+7,852
+4% +$285K
CL icon
297
Colgate-Palmolive
CL
$73.3B
$8.1M 0.04%
102,516
-233,401
-69% -$18.3M
NTRS icon
298
Northern Trust
NTRS
$22.4B
$8.02M 0.04%
58,723
+37,550
+177% +$4.93M
ORA icon
299
Ormat Technologies
ORA
$5.94B
$7.95M 0.04%
71,988
-1,232
-2% -$135K
PAAS icon
300
Pan American Silver
PAAS
$18.6B
$7.88M 0.04%
+152,000
New +$6.36M

Similar funds

Candriam SCA's Q4 2025 Portfolio in Review

As of Q4 2025, Candriam SCA held 721 positions worth $20.1B, up 5% from $19.1B the previous quarter. Its ten largest holdings account for 32% of the portfolio.

Candriam SCA's Q4 2025 filing shows 63 new, 299 increased, 261 reduced and 36 closed positions. Its largest new stake was Alibaba: 276,080 shares worth $40.5M. The largest sale was Equinix, an estimated $50.3M.

By sector, the portfolio is most concentrated in Technology at 34% of assets, down from 37% a quarter earlier, followed by Healthcare and Financials.

  • Candriam SCA's largest Q4 2025 buy was Alibaba: 276,080 shares worth $40.5M.
  • Candriam SCA added most to AbbVie in Q4 2025, an estimated $55.1M increase.
  • Candriam SCA's biggest Q4 2025 reduction was Equinix, cutting an estimated $50.3M.
  • Candriam SCA fully exited Universal Display in Q4 2025, selling an estimated $27.1M.
  • Candriam SCA's ten largest holdings make up 32% of its $20.1B portfolio in Q4 2025.
  • Candriam SCA opened 63 new positions and closed 36 in Q4 2025.
  • Candriam SCA's portfolio value rose 5% quarter-over-quarter to $20.1B.

Based on Candriam SCA's 13F filing for Q4 2025, filed 13 Feb 2026.